Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective-Reference-Cited by-同舟云学术

Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective

Published:2018 Issue:3 Volume:65 Page:345-357
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Higuchi Tetsuya¹,Achmad Arifudin¹²,Binh Duong Duc¹³,Bhattarai Anu¹⁴,Tsushima Yoshito¹

Affiliation:

1. Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan

2. Department of Nuclear Medicine and Molecular Imaging, Faculty of Medicine, Padjadjaran University, West Java 40161, Indonesia

3. Department of Diagnostic Radiology and Nuclear Medicine, VINMEC Times City hospital, Ha Noi city 100000, Vietnam

4. National Academy of Medical Sciences Bir Hospital, Kanti Path, Kathmandu 44600, Nepal

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/65/3/65_EJ17-0343/_pdf

Reference40 articles.

1. 1 Global Burden of Disease Cancer Collaboration (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3: 524–548.

2. 2 Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, et al. (2015) Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 45: 884–891.

3. 3 Saika K, Matsuda T, Sobue T (2014) Incidence rate of thyroid cancer by histological type in Japan. Jpn J Clin Oncol 44: 1131–1132.

4. 4 Chereau N, Buffet C, Tresallet C, Tissier F, Leenhardt L, et al. (2016) Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: predictive factors and operative management. Surgery 159: 755–762.

5. 5 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26: 1–133.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outpatient ablation treatment with two doses of 30 mCi of radioactive iodine for non-low-risk papillary thyroid cancer;The Journal of Medical Investigation;2023

2. Radioactive iodine treatment of papillary thyroid carcinoma in Japan;Gland Surgery;2020-10

3. Relationship between thyroid tumor radiosensitivity and nuclear localization of DNA-dependent protein kinase catalytic subunit;Journal of Radiation Research;2020-06-22

4. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer;Annals of Nuclear Medicine;2019-12-13